YOYEN ESPARTERO: Open Payments
NPI 1972981348 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,071 in 19 payments from 7 companies in 2025. Trend: 2023 $131 · 2024 $573 · 2025 $2,071
Travel & lodging: $1,233Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $1,739 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Novo Nordisk Inc | 3 | $68 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $20 |
Products named: NURTEC ODT, CAPLYTA, FARXIGA, AIRSUPRA, TZIELD, Kerendia, Ozempic, MOUNJARO.
Industry payments across NV — which companies pay providers there.
